Indications and uses
• helps prevent sunburn
• helps prevent sunburn
• apply daily after cleansing and toning • smooth over face and throat • apply liberally 15 minutes before sun exposure • children under 6 months of age: Ask a doctor • reapply at least every 2 hours • use a water resistant sunscreen if swimming or sweating • Sun Protection Measures. Spending time in the sun increase your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen wi...
Avobenzone 3.0%
Octinoxate 7.5%
Octisalate 5.0%
Octocrylene 2.5%
Sunscreen
• helps prevent sunburn
For external use only
on damaged or broken skin
keep out of eyes. Rinse with water to remove.
rash occurs
If product is swallowed, get medical help or contact a Poison Control Center right away.
• apply daily after cleansing and toning • smooth over face and throat • apply liberally 15 minutes before sun exposure • children under 6 months of age: Ask a doctor • reapply at least every 2 hours • use a water resistant sunscreen if swimming or sweating • Sun Protection Measures. Spending time in the sun increase your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: • Limit time in the sun, especially from 10 a.m. - 2 p.m. • Wear long-sleeve shirts, pants, hats and sunglasses
Water (Aqua), C12-15 Alkyl Ethylhexanoate, Glycerin, Dimethicone/Vinyl Dimethicone Crosspolymer, Polyglyceryl-3 Methylglucose Distearate, Helianthus Annuus (Sunflower) Seed Oil Unsaponifiables, Steareth-21, Behenyl Alcohol, Butylene Glycol, Glycoproteins*, Panax Ginseng Root Extract*, Equisetum Arvense Extract*, Sodium Hyaluronate, Caprooyl Tetrapeptide-3, Salicornia Herbacea Extract, Sodium PCA, Triacetin, Tocopheryl Acetate, Resveratrol, Lactobacillus Ferment, Acetyl Decapeptide-3, Trehalose, Urea, Larix Sibirica Wood Extract, Palmitoyl Tripeptide-8, Carnosine, Potato Starch Modified, Disodium EDTA , Myrothamnus Flabellifolia Leaf Extract, Kefiran, Sodium Hydroxide, Glyceryl Stearate, Chlorella Vulgaris Extract, Silica, Panthenol, Polyquaternium-51, Glycine Soja (Soybean) Oil, PEG-100 Stearate, Hydrogenated Lecithin, Allantoin, Hydroxyethyl Behenamidopropyl Dimonium Chloride, C13-14 Isoparaffin, Dextran, Caprylic/Capric Triglyceride, Polysorbate 80, Sodium Oleate, Laureth-7, Saccharomyces Cerevisiae Extract, Cetyl Dimethicone, Caprylyl Glycol, Polyquaternium-67, Steareth-2, Polyacrylamide, Carbomer, Synthetic Wax, Alcohol, Fragrance (Parfum), Linalool, Hexyl Cinnamal, Hydroxycitronellal, Alpha-Isomethyl Ionone, Geraniol, Citronellol, Benzyl Benzoate, Butylphenyl Methylpropional, Evernia Furfuracea (Treemoss) Extract, Eugenol, Benzyl Salicylate, Ethylhexylglycerin, Phenoxyethanol, Sorbic Acid, Sodium Dehydroacetate, Chlorphenesin, Methylparaben, Benzoic Acid, Yellow 5 (CI 19140), Red 4 (CI 14700) i73 * La Prairie’s exclusive Cellular Complex US Patent 5,840,309
• Protect the product in this container from excessive heat and direct sun
Call toll free 1-800-821-5718 or visit
www.laprairie.com
CLARENS/MONTREUX • ZURICH D-76530 BADEN-BADEN MILANO • PARIS LA PRAIRIE, INC., DISTR. NEW YORK, N.Y. 10019
ANTI-AGING DAY CREAM SUNSCREEN BROAD SPECTRUM CREME DE JOUR ANTI-AGE CREME SOLAIRE LARGE SPECTRE SPF 30 la prairie SWITZERLAND 50 ml e / NET WT. 1.7 OZ. MADE IN SWITZERLAND
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| AVOBENZONE | ACTIVE INGREDIENT | G63QQF2NOX | 6 | |
| OCTINOXATE | ACTIVE INGREDIENT | 4Y5P7MUD51 | 6 | |
| OCTISALATE | ACTIVE INGREDIENT | 4X49Y0596W | 6 | |
| OCTOCRYLENE | ACTIVE INGREDIENT | 5A68WGF6WM | 6 | |
| AVOBENZONE | ACTIVE MOIETY | G63QQF2NOX | 6 | |
| OCTINOXATE | ACTIVE MOIETY | 4Y5P7MUD51 | 6 | |
| OCTISALATE | ACTIVE MOIETY | 4X49Y0596W | 6 | |
| OCTOCRYLENE | ACTIVE MOIETY | 5A68WGF6WM | 6 | |
| .ALPHA.-HEXYLCINNAMALDEHYDE | INACTIVE INGREDIENT | 7X6O37OK2I | 6 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 6 | |
| ALLANTOIN | INACTIVE INGREDIENT | 344S277G0Z | 6 | |
| BENZOIC ACID | INACTIVE INGREDIENT | 8SKN0B0MIM | 6 | |
| BENZYL BENZOATE | INACTIVE INGREDIENT | N863NB338G | 6 | |
| BENZYL SALICYLATE | INACTIVE INGREDIENT | WAO5MNK9TU | 6 | |
| BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 6 | |
| BUTYLPHENYL METHYLPROPIONAL | INACTIVE INGREDIENT | T7540GJV69 | 6 | |
| C13-14 ISOPARAFFIN | INACTIVE INGREDIENT | E4F12ROE70 | 6 | |
| CAPROOYL TETRAPEPTIDE-3 | INACTIVE INGREDIENT | LZI0HJ3K2R | 6 | |
| CAPRYLYL GLYCOL | INACTIVE INGREDIENT | 00YIU5438U | 6 | |
| CARNOSINE | INACTIVE INGREDIENT | 8HO6PVN24W | 6 | |
| CHLORELLA VULGARIS | INACTIVE INGREDIENT | RYQ4R60M02 | 6 | |
| CHLORPHENESIN | INACTIVE INGREDIENT | I670DAL4SZ | 6 | |
| DOCOSANOL | INACTIVE INGREDIENT | 9G1OE216XY | 6 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | 6 | |
| ETHYLHEXYLGLYCERIN | INACTIVE INGREDIENT | 147D247K3P | 6 | |
| EUGENOL | INACTIVE INGREDIENT | 3T8H1794QW | 6 | |
| FD&C RED NO. 4 | INACTIVE INGREDIENT | X3W0AM1JLX | 6 | |
| FD&C YELLOW NO. 5 | INACTIVE INGREDIENT | I753WB2F1M | 6 | |
| GERANIOL | INACTIVE INGREDIENT | L837108USY | 6 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 6 | |
| GLYCERYL MONOSTEARATE | INACTIVE INGREDIENT | 230OU9XXE4 | 6 | |
| HYALURONATE SODIUM | INACTIVE INGREDIENT | YSE9PPT4TH | 6 | |
| HYDROXYCITRONELLAL | INACTIVE INGREDIENT | 8SQ0VA4YUR | 6 | |
| ISOMETHYL-.ALPHA.-IONONE | INACTIVE INGREDIENT | 9XP4LC555B | 6 | |
| LARIX SIBIRICA WOOD | INACTIVE INGREDIENT | KSC3PGF73L | 6 | |
| LAURETH-7 | INACTIVE INGREDIENT | Z95S6G8201 | 6 | |
| LINALOOL, DL- | INACTIVE INGREDIENT | D81QY6I88E | 6 | |
| MEDIUM-CHAIN TRIGLYCERIDES | INACTIVE INGREDIENT | C9H2L21V7U | 6 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | 6 | |
| PANTHENOL | INACTIVE INGREDIENT | WV9CM0O67Z | 6 | |
| PEG-100 STEARATE | INACTIVE INGREDIENT | YD01N1999R | 6 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 6 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | 6 | |
| PSEUDEVERNIA FURFURACEA | INACTIVE INGREDIENT | 49ZMN09Q0K | 6 | |
| RESVERATROL | INACTIVE INGREDIENT | Q369O8926L | 6 | |
| SALICORNIA EUROPAEA | INACTIVE INGREDIENT | 6ADL50JAKW | 6 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 6 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | 6 | |
| SODIUM OLEATE | INACTIVE INGREDIENT | 399SL044HN | 6 | |
| SODIUM PYRROLIDONE CARBOXYLATE | INACTIVE INGREDIENT | 469OTG57A2 | 6 | |
| SORBIC ACID | INACTIVE INGREDIENT | X045WJ989B | 6 | |
| SOYBEAN OIL | INACTIVE INGREDIENT | 241ATL177A | 6 | |
| STEARETH-2 | INACTIVE INGREDIENT | V56DFE46J5 | 6 | |
| STEARETH-21 | INACTIVE INGREDIENT | 53J3F32P58 | 6 | |
| TREHALOSE | INACTIVE INGREDIENT | B8WCK70T7I | 6 | |
| UREA | INACTIVE INGREDIENT | 8W8T17847W | 6 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 6 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 68026-503 | 68026-503-50, 68026-503-05, 68026-503-01, 68026-503-07, 68026-503-15 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / INTRALESIONAL | 0.15 %w/v | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | SPRAY / TOPICAL | 540 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, SUSPENSION / INTRALESIONAL | 4 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | SUSPENSION / ORAL | 206 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER / ORAL | 602 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | LOTION / TOPICAL | 351 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SPRAY / NASAL | 1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, CHEWABLE / ORAL | 12 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | LIQUID / TOPICAL | 1 %w/w | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | LIQUID / ORAL | 2 mg/1ml | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | ELIXIR / ORAL | 2.5 mg/15ml | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | CONCENTRATE / ORAL | 20 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | GRANULE, FOR SUSPENSION / ORAL | 4 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | CONCENTRATE / ORAL | 12 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION/ DROPS / OPHTHALMIC | 0.13 %w/v | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | SUSPENSION/ DROPS / OPHTHALMIC | 1 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRACARDIAC | 2 mg | ||
| FD&C YELLOW NO. 5 | FD&C YELLOW NO. 5 | I753WB2F1M | CAPSULE / ORAL | 652 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION / INTRAVENOUS | 4680 mg | ||
| SORBIC ACID | SORBIC ACID | X045WJ989B | SOLUTION/ DROPS / OPHTHALMIC | 0.2 %w/v | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRAVITREAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRAVASCULAR | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION, EXTENDED RELEASE / INTRALESIONAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / URETERAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / SOFT TISSUE | ADJ PH | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, FILM COATED / ORAL | 1.55 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SUSPENSION / INTRAMUSCULAR | 1 mg | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | SUSPENSION / ORAL | 15 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | LIQUID / ORAL | 2 mg/5ml | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / SOFT TISSUE | 0.15 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, ORALLY DISINTEGRATING / ORAL | 3 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CLOTH / TOPICAL | 0.05 mg/mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, COATED / ORAL | 0.21 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | PASTE / DENTAL | 34 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SUSPENSION / SUBCUTANEOUS | 0.16 %w/v | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, SUSPENSION / SUBCUTANEOUS | 0.3 %w/v | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / RESPIRATORY (INHALATION) | 8 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| FD&C YELLOW NO. 5 | FD&C YELLOW NO. 5 | I753WB2F1M | SYRUP / ORAL | 0.1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | ELIXIR / ORAL | 5621 mg | ||
| FD&C YELLOW NO. 5 | FD&C YELLOW NO. 5 | I753WB2F1M | TABLET, DELAYED RELEASE / ORAL | 3 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / IONTOPHORESIS | 168.1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / OPHTHALMIC | 2.5 %w/v | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / BUCCAL | 3 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRAVASCULAR | 0.48 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TAMPON / VAGINAL | NA | ||
| FD&C YELLOW NO. 5 | FD&C YELLOW NO. 5 | I753WB2F1M | TABLET, FILM COATED / ORAL | 1.68 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / SUBCUTANEOUS | 15 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / INTRAMUSCULAR | 45 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / INTRATHECAL | ADJ PH | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | POWDER, FOR SUSPENSION / ORAL | 285 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRATHECAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | ENEMA / RECTAL | 0.44 %v/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / INTRAVENOUS | 0.05 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, EXTENDED RELEASE / ORAL | 265 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION / ENDOTRACHEAL | ADJ PH | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET, DELAYED RELEASE / ORAL | 6 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 764e97e0-9847-4baa-e053-2991aa0ac622 | 91cdadde-c7a0-4060-9457-4b116dbc79a3 | 2018-09-20 | Warnings | 764e97e0-9847-4baa-e053-2991aa0ac622 91cdadde-c7a0-4060-9457-4b116dbc79a3 |
Adverse event summaries are temporarily unavailable. Other product information remains available.